Abstract
SAR405 is a first-in-class VPS34 inhibitor that disrupts vesicle trafficking and blocks autophagy.
©2014 American Association for Cancer Research.
2014
You do not currently have access to this content.
Advertisement
A VPS34-Specific Inhibitor Blocks Autophagy and Has Anticancer Activity. Cancer Discov 1 December 2014; 4 (12): OF9. https://doi.org/10.1158/2159-8290.CD-RW2014-227
Download citation file:
SAR405 is a first-in-class VPS34 inhibitor that disrupts vesicle trafficking and blocks autophagy.
Advertisement